General Updates Suven Life Sciences Limited has informed the Exchange rectification order for assesment year 2020-21 Suven Life Sciences Limited has informed the Exchange rectification order for assesment year 2020-21
General Updates Suven Life Sciences Limited has informed the Exchange rectification order for assesment year 2020-21 Suven Life Sciences Limited has informed the Exchange rectification order for assesment year 2020-21
Company Update Rectification order for Assesment year 2020-21 Rectification order for Assesment year 2020-21
Company Update Rectification order for Assesment year 2020-21 Rectification order for Assesment year 2020-21
💹 Change: ▼ -2.34% 💰 Price: ₹268.90 📊 Volume: 2.41M 🔍 What's happening? Unusual trading activity detected! This could signal a potential breakout or significant news impact. 💡 Pro Tip: Always conduct thorough research before making investment decisions.
Suven Life Sciences (SUVEN) stock fell 0.71% to ₹273.40 with 2.22 million shares traded, signaling unusual trading activity on Tuesday.
Suven Life Sciences (NSE: SUVEN) announced positive findings from a DSMB safety review and interim analysis of its ongoing global Phase 3 study of Masupirdine for Alzheimer's Disease Agitation.
SUVEN LIFE SCIENCES Q3 FY25 Results
SUVEN LIFE SCIENCES Q2 FY25 Results
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.